SAGE PRO

Home / Research / Gabriel India Limited

SAGE PRO · ORIGINAL EQUITY RESEARCH

Gabriel India Limited — Q2 FY27 Results Analysis

Revenue expanded 22.9%

Published · Quarter Q2 FY27 · GABRIEL

PeriodQ2 FY27
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Consolidated revenue

Q2 FY26₹13,083 million
Q2 FY27₹16,080 million

https://nsearchives.nseindia.com/corporate/GABRIEL_31102026224612_SE_Intimation_signed.pdf

CHART 2

Consolidated EBITDA

Q2 FY26₹1,259 million
Q2 FY27₹1,409 million

https://nsearchives.nseindia.com/corporate/GABRIEL_31102026224612_SE_Intimation_signed.pdf

CHART 3

Consolidated EBITDA margin

Q2 FY269.6%
Q2 FY278.8%

https://nsearchives.nseindia.com/corporate/GABRIEL_31102026224612_SE_Intimation_signed.pdf

CHART 4

Consolidated PBT before exceptions

Q2 FY26₹1,301 million
Q2 FY27₹1,482 million

https://nsearchives.nseindia.com/corporate/GABRIEL_31102026224612_SE_Intimation_signed.pdf

ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Revenue expanded 22.9%

Demand was strong, but margins narrowed

Watch: Track operating leverage

RESEARCH INSIGHT

EBITDA grew more slowly than sales

Operating profit conversion weakened

Watch: Watch cost and mix

RESEARCH INSIGHT

Margin declined by 0.8 percentage points

Strong volume did not protect profitability

Watch: Track recovery

RESEARCH INSIGHT

PBT improved

Joint-venture earnings are increasingly important

Watch: Reconcile operating and associate profit

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

Gabriel India Limited | Q2 FY27, quarter ended 30 September 2026 | WATCH

Gabriel's automotive components business grew quickly in the September quarter, but operating profit grew more slowly than sales. Consolidated revenue rose 22.9% to ₹1,608 crore (₹16,080 million), while EBITDA increased 11.9% to ₹141 crore (₹1,409 million). The difference matters: the consolidated EBITDA margin was 8.8%, down from 9.6% a year earlier. Strong demand is encouraging, but the investor needs evidence that the expanded business can protect profit margins as it grows. [S1][S2]

The company is also changing its structure. Investments in automotive joint ventures, including HL Mando Anand and HL Klemove, broaden Gabriel's exposure beyond conventional suspension products. HL Mando Anand contributed only a few days of earnings after the 11 September 2026 transaction. At the same time, Gabriel issued up to ₹1,000 crore of non-convertible debentures carrying an 8.15% fixed annual coupon. That makes future cash returns and financing costs more important than headline revenue growth alone. [S1][S2]

MetricQ2 FY26Q2 FY27Reporting basis
Revenue₹1,308.3 crore₹1,608.0 croreConsolidated
EBITDA₹125.9 crore₹140.9 croreConsolidated, presentation basis
EBITDA margin9.6%8.8%Consolidated
PBT before exceptional items₹130.1 crore₹148.2 croreConsolidated
Revenue₹1,140.3 crore₹1,399.2 croreStandalone
EBITDA₹99.8 crore₹114.9 croreStandalone
EBITDA margin8.8%8.2%Standalone

What changed and why it matters

  • Consolidated revenue grew 22.9% year on year in Q2, reflecting stronger sales and a broader operating structure. [S1][S2]
  • Consolidated EBITDA grew 11.9%, slower than revenue, so the margin narrowed by 0.8 percentage points. [S2]
  • Consolidated PBT before exceptional items grew 13.9%, to ₹148.2 crore, including the effect of equity-accounted investments. [S1][S2]
  • Standalone revenue rose 22.7%, while standalone EBITDA grew 14.6%; the standalone margin fell from 8.8% to 8.2%. [S2]
  • First-half consolidated revenue reached ₹3,033.7 crore, up 19.3%, showing that growth was not limited to a single quarter. [S2]
  • First-half consolidated EBITDA reached ₹265.0 crore, up 8.6%, indicating continued pressure on profitability relative to sales. [S2]
  • The equity-accounted investees' share of PBT was ₹48 crore in Q2, up 39%, but the newest investment contributed for only a few days. [S1]
  • Gabriel reported 32 net working-capital days at September-end, a useful measure of cash tied up in operations. [S2]
  • The presentation reports ₹66.7 crore capex for the period ended September 2026; its period label should be checked before treating it as quarterly expenditure. [S2]
  • The new ₹1,000 crore debenture funding at 8.15% changes the balance-sheet and future interest-cost discussion. [S2]
  • Management said supplies had begun for the Bajaj Chetak electric scooter, adding a concrete customer programme. [S1]
  • Management described a planned FORVIA seating joint venture, but did not give a firm transferable revenue or margin number for the proposed transaction. [S1]

Chapter 1 — Investment decision and valuation requirements

Gabriel is no longer only a conventional shock-absorber and suspension-parts company. Its core business serves two-wheelers, passenger vehicles, commercial vehicles and the aftermarket, while new partnerships add electronics, steering, braking, driveline and seating-related opportunities. This makes the growth opportunity larger, but also makes the consolidated financial statements harder to read. Investors need to distinguish businesses Gabriel controls from joint ventures whose earnings are recognised through the equity method. [S1][S2]

The near-term decision is WATCH, not because demand is weak, but because revenue is growing faster than EBITDA and the financing structure has changed. The presentation shows consolidated Q2 revenue growth of 22.9%, against EBITDA growth of 11.9%. If this difference persists, greater scale will not automatically produce proportionate shareholder earnings. The right valuation test is whether operating margins recover and whether the enlarged joint-venture portfolio earns enough to cover its capital and financing costs. [S2]

A market-price-based target cannot be derived from the two accepted quarterly documents alone: they do not provide a current share price, a complete market-value bridge or a defensible consolidated free-cash-flow forecast. A higher-confidence valuation would require current enterprise value, the economics of the equity-accounted ventures, the cost of debenture funding and a consistent post-reorganisation earnings base.

Chapter 2 — Q2 and H1 financials: growth versus profit conversion

The consolidated presentation shows revenue of ₹16,080 million in Q2 FY27, compared with ₹13,083 million in Q2 FY26 and ₹14,257 million in Q1 FY27. EBITDA was ₹1,409 million, versus ₹1,259 million and ₹1,242 million, respectively. Revenue grew 12.8% sequentially; EBITDA grew 13.5% sequentially. That sequential recovery is helpful, but the year-on-year EBITDA margin still fell from 9.6% to 8.8%. [S2]

Consolidated PBT before exceptional items was ₹1,482 million, compared with ₹1,301 million in Q2 FY26 and ₹1,333 million in Q1 FY27. This PBT measure is not identical to operating EBITDA. In particular, equity-accounted investees contributed a ₹48 crore share of profit before tax in Q2, which management said grew 39% year on year. The mix of operating-company profit and associate profit is increasingly important when comparing quarters. [S1][S2]

For the first half, consolidated revenue was ₹30,337 million versus ₹25,427 million a year earlier. EBITDA was ₹2,650 million versus ₹2,440 million implied by the company's stated 8.6% growth, while the presentation's half-year margin is 8.7%, versus 9.6% in H1 FY26. The half-year PBT figures shown are ₹2,814 million and ₹2,558 million, with 10.0% reported growth. Half-year results provide a broader view than a single September quarter and reinforce the same pattern: sales are expanding faster than operating profit. [S2]

Standalone results show the same pressure. Revenue increased from ₹11,403 million to ₹13,992 million, but EBITDA increased from ₹998 million to ₹1,149 million. The standalone EBITDA margin declined from 8.8% to 8.2%. Standalone PBT was ₹1,003 million compared with ₹886 million a year earlier. These standalone numbers should not be substituted for consolidated results or added to them. [S2]

The presentation notes a retrospective pooling-of-interests treatment following a composite arrangement involving Anchemco India and Asia Investments. It also describes adjustments to some historical EBITDA and PBT measures for non-operating items and the FY26 wage-code impact. Accordingly, investors should compare the presentation's like-for-like series, then reconcile with the statutory filing before treating any adjusted margin as a permanent run rate. [S2]

Chapter 3 — Customers, channels and the economics of the product mix

Management said the wider Indian automotive market remained strong in Q2 FY27. It cited 16.5% year-on-year growth in two-wheeler production, 25% growth in passenger-vehicle production and 34% growth in commercial-vehicle production. These are industry production figures, not Gabriel's own sales growth rates. They help explain the demand environment, but they do not measure Gabriel's pricing power or market-share gains. [S1]

Within the standalone business, the presentation shows a meaningful mix of original-equipment customers, exports and the aftermarket. The standalone channel-mix charts identify 91% OEM and 9% aftermarket in Q2 FY27, versus 88% OEM and 12% aftermarket in Q1 FY27. A higher original-equipment share can support volume but may expose margins to customer pricing negotiations. The precise economic effect cannot be established without product-level contribution margins. [S2]

Management said supplies had started for Bajaj's Chetak electric scooter, and discussed additional programmes across electric two-wheelers. That is a concrete customer addition, but the transcript does not disclose the revenue, profit margin or annualised value of the programme. The useful next step is to watch whether these wins lift organic sales and margins together, rather than assuming all EV-related content is high-margin. [S1]

Sunroof products and seating are further growth avenues. The company described an expansion of sunroof model coverage and a proposed partnership with FORVIA in automotive seating. Analysts asked what part of FORVIA's existing India business would transfer, since seat mechanisms were outside the planned scope. Management did not provide a firm transferred revenue or margin estimate. That uncertainty matters because transaction headlines should not be converted into immediate earnings forecasts. [S1][S2]

Chapter 4 — Execution, joint ventures and questions raised on the call

Gabriel's expanded portfolio includes Dana Anand, Henkel Anand, SK Enmove Gabriel, HL Mando Anand and HL Klemove. The company reported ₹48 crore in Q2 share of PBT from equity-accounted investees, compared with a lower base a year earlier, and ₹91 crore for H1 FY27. Management emphasised that the September 11 investment in HL Mando Anand contributed for only a few days. A full quarter of ownership will make subsequent comparisons different even without a change in the underlying business. [S1]

This is the key accounting distinction: a joint venture can add to Gabriel's share of profit without its entire revenue appearing in consolidated operating sales. Investors who divide group profit by only the controlled operating revenue can misread the underlying margin. The investor presentation's group charts and the call's equity-accounted earnings disclosure should therefore be read together. [S1][S2]

On the FORVIA seating proposal, an analyst cited an existing business run rate of about ₹250 crore and asked how much would actually move to Gabriel after excluding mechanisms. Management did not establish a final transferable revenue or margin figure. This is a real unresolved deal-economics question, not a reason to insert the analyst's number into a forecast. [S1]

Another analyst asked whether the new seating venture had anchor orders. Management said existing Volkswagen business was expected to come with the venture, but declined to quantify the order book before closing. This makes order conversion and the final transaction perimeter important next-quarter checkpoints. [S1]

Chapter 5 — Capital allocation, debt, working capital and cash returns

The standalone balance sheet changed sharply by September 2026. Total assets were ₹57,277 million, versus ₹23,746 million in March 2026, while standalone equity rose to ₹34,218 million from ₹14,521 million. Non-current assets rose to ₹41,771 million from ₹9,798 million. The presentation attributes part of the change in net worth to strategic investments under Project Jupiter and Project Rise, alongside the retrospective arrangement. These figures show a structural change in the asset base; they do not by themselves establish the return earned on the new investments. [S2]

The company disclosed issuance of up to ₹10,000 million in unsecured listed non-convertible debentures, at a fixed 8.15% annual coupon. On the full stated principal, the simple annual coupon would be ₹815 million, before considering issuance timing and other financing terms. That calculation is a financing sensitivity, not an assertion that the full amount was outstanding for the entire quarter or that this equals the reported interest expense. The investor should compare the cost of these funds with the actual cash and equity-method returns generated by the investments. [S2]

Gabriel reported 32 net working-capital days for the period ended September 2026, and capex of ₹667 million for the period ended September 2026. The extracted presentation does not clearly establish whether the latter amount is Q2-only or H1-to-date, so it is not used to calculate a quarterly free-cash-flow figure. A complete consolidated cash-flow statement and the cash received from associates are needed before estimating payback on the new investments. [S2]

The board also declared an interim dividend of ₹2.15 per share on shares with ₹1 face value. That is a shareholder-distribution decision, not proof of excess free cash after acquisition funding. Dividend sustainability should be assessed alongside debt servicing, future capex and actual cash distributions from joint ventures. [S1]

Chapter 6 — Bull, base and bear outcomes

Bull case: Strong vehicle demand continues, new EV and sunroof programmes gain volume, the FORVIA seating venture closes with a commercially attractive scope, and the newly acquired interests begin contributing meaningful recurring profits. Consolidated EBITDA growth catches up with revenue growth, while working capital and financing costs remain controlled. This case would be supported by margin recovery above the Q2 8.8% consolidated level and transparent joint-venture cash returns. [S1][S2]

Base case: Revenue continues to grow, but customer pricing, product mix and integration spending keep EBITDA growth below sales growth. Equity-accounted profits support PBT, while the enlarged balance sheet and fixed-coupon debentures increase the importance of capital efficiency. This would justify watching the stock until more comparable post-transaction quarters are available.

Bear case: Industry volumes slow, new programmes ramp more slowly than expected, and seating or electronics investments require additional capital before producing cash. Margins remain below their prior-year levels, while interest costs absorb a larger share of operating improvement. The risk is not simply weak demand; it is that a larger business generates an inadequate return on a much larger capital base.

What would change the assessment

  • A sustained recovery in consolidated EBITDA margin from 8.8% toward or above the prior-year 9.6% would support better earnings conversion. [S2]
  • Continued divergence between revenue and EBITDA growth would weaken the operating leverage argument. [S2]
  • Clearer disclosure of the contribution and cash distributions from equity-accounted ventures would improve valuation confidence. [S1]
  • Final FORVIA deal scope and confirmed Volkswagen orders would reduce uncertainty around seating economics. [S1]
  • Evidence that debenture-funded investments earn more than their financing cost would strengthen the capital-allocation case. [S2]

Chapter 7 — Investment action plan and next-quarter watchlist

Current stance: WATCH. Gabriel has a strong demand backdrop and a broader opportunity set, but Q2 results also show margin dilution and a major change in its capital structure. The next two quarters should reveal whether new businesses improve recurring earnings and cash returns or mainly add complexity.

Indicator to monitorQ2 FY27 referenceWhy it matters
Consolidated revenue₹1,608 croreTests sales momentum
Consolidated EBITDA₹141 croreTests operating profit conversion
Consolidated EBITDA margin8.8%Tests pricing, cost and product mix
Consolidated PBT before exceptions₹148.2 croreIncludes wider group economics
Standalone EBITDA margin8.2%Tracks legacy operating business
Equity-accounted share of PBT₹48 croreTracks joint-venture earnings
Standalone net working-capital days32 daysTracks cash tied up in operations
Fixed-coupon NCD issuanceUp to ₹1,000 crore at 8.15%Tracks cost of expansion capital
Standalone equity₹3,421.8 croreTracks capital deployed after restructuring
Interim dividend₹2.15 per shareTracks distribution against funding needs

Specific questions for management next quarter

  • How much of the revenue increase came from volume, pricing, acquisitions and product mix? [S1][S2]
  • What actions can recover the 0.8-point year-on-year consolidated EBITDA margin decline? [S2]
  • What is the full-quarter profit contribution from HL Mando Anand after its September acquisition date? [S1]
  • How much cash, rather than only accounting profit, will the new joint ventures distribute? [S1]
  • What assets, revenue and margin will actually transfer into the FORVIA seating venture at closing? [S1]
  • What is the outstanding debenture balance, interest expense and funding schedule? [S2]
  • Can management reconcile period capex, consolidated operating cash flow and investment spending? [S2]

The central investment question is whether Gabriel can turn a 22.9% revenue increase into stronger per-share cash earnings while financing a much larger set of automotive businesses. The next results should be judged on margin recovery, venture economics and cash conversion—not just new partnerships or order announcements.

Original company and exchange sources

*₹ crore and ₹ million are shown explicitly; ₹10 million equals ₹1 crore. Consolidated, standalone, equity-accounted and management-adjusted measures are not interchangeable.*

Additional company evidence

CHART 5

H1 consolidated revenue

H1 FY26₹25,427 million
H1 FY27₹30,337 million

https://nsearchives.nseindia.com/corporate/GABRIEL_31102026224612_SE_Intimation_signed.pdf

CHART 6

H1 consolidated PBT

H1 FY26₹2,558 million
H1 FY27₹2,814 million

https://nsearchives.nseindia.com/corporate/GABRIEL_31102026224612_SE_Intimation_signed.pdf

CHART 7

Standalone revenue

Q2 FY26₹11,403 million
Q2 FY27₹13,992 million

https://nsearchives.nseindia.com/corporate/GABRIEL_31102026224612_SE_Intimation_signed.pdf

CHART 8

Standalone EBITDA

Q2 FY26₹998 million
Q2 FY27₹1,149 million

https://nsearchives.nseindia.com/corporate/GABRIEL_31102026224612_SE_Intimation_signed.pdf

SOURCE REFERENCES

Original disclosures and investor presentations

  1. Issuer disclosure

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.